Wuhan Huakang Century Clean Technology Co., Ltd. (SHE:301235)
48.89
-0.58 (-1.17%)
At close: Jan 23, 2026
SHE:301235 Revenue
Wuhan Huakang Century Clean Technology had revenue of 596.57M CNY in the quarter ending September 30, 2025, with 13.48% growth. This brings the company's revenue in the last twelve months to 2.06B, up 34.09% year-over-year. In the year 2024, Wuhan Huakang Century Clean Technology had annual revenue of 1.71B with 6.64% growth.
Revenue (ttm)
2.06B
Revenue Growth
+34.09%
P/S Ratio
2.48
Revenue / Employee
1.20M
Employees
1,723
Market Cap
5.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.71B | 106.27M | 6.64% |
| Dec 31, 2023 | 1.60B | 412.66M | 34.71% |
| Jan 1, 2023 | 1.19B | 328.10M | 38.12% |
| Jan 1, 2022 | 860.81M | 98.99M | 12.99% |
| Dec 31, 2020 | 761.82M | 159.67M | 26.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 7.22B |
| Shenzhen Lifotronic Technology | 1.05B |
| Getein Biotech | 1.04B |
| Shanghai Kinetic Medical | 1.02B |
| Zhejiang Orient Gene Biotech | 842.11M |
| Hangzhou AGS MedTech | 668.70M |
| Chison Medical Technologies | 449.62M |
| Nanjing Medlander Medical Technology | 437.82M |